Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

LAVOXEN TABLET 200 mg

Approval Number

SIN12299P

Drug Name

LAVOXEN TABLET 200 mg

Product Name

LAVOXEN TABLET 200 mg

Approval Date

May 22, 2003

Registrant

SHOEI UNIVERSAL CORPORATION PTE LTD

Licence Holder

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

Registrant

SHOEI UNIVERSAL CORPORATION PTE LTD

Licence Holder

SHOEI UNIVERSAL CORPORATION PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

G04BD02

ATC Item Name

flavoxate

Manufacturer Information

Pharmaceutical Manufacturer

SHOEI UNIVERSAL CORPORATION PTE LTD

Manufacturers

DAE HAN NEW PHARM. CO. LTD.

Active Ingredients

Ingredient Name

FLAVOXATE HCl

Strength

200 mg

Drug MonographFlavoxate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy